2. Hematuria 3. Skeletal pain 4. Renal insufficiency
Skeletal p tral zone: . Transition zon. .
A 58-year old male comes into your office for a physical examination to
qualify for a life insurance policy. On digital rectal examination, he is found to
have a 1.5cm non-tender, firm nodule at the right apex of his prostate. His
PSA was checked 7 months ago and was found to be 1.9ng/ml. What is the
2. Refer to urologist 3. Urinary dipstick and
Which of the following alternatives are not first choice
therapy in moderately differentiated local prostate
2. ”Watchful waiting” 3. TUR P 4. Radikal
atchful w ikal prosta. B Extern strålbe. .
2. Pelvic lgll then spine 3. Inguinal lgll then
ikula sem Pelvic lg Inguinal lgll .
A 68-year old male diagnosed with localized prostate cancer (Gleason 6, PSA
4.3 ng/ml, normal prostate exam) is trying to decide between therapy with
external beam radiotherapy (XRT), brachytherapy (placement of radioactive
seeds in the prostate), or radical prostatectomy. What is a major side effect of
2. ED 3. Loss of Libido 4. Peyronies disease
A 76-year old male was lost to follow-up after his radical prostatectomy for
prostate cancer 10 years ago and now presents to the emergency department
with new hip pain. Plain films show osteoblastic metastases to his pelvis,
femurs and spine. PSA level is 324 ng/ml. His neurologic examination is
normal. What is the most appropriate form of therapy for this patient?
ical prosta. onal thera External radio.
All the following are riskfactors for ED
tand yper Pelvic surger
All of the following are side-effects of
lue vision Sudden death w
Which of the following groups of urological
lpha 1 block nticholin Phosphodiester. .
A 58-year old male presents with severe lower urinary tract symptoms (weak
stream, straining to empty, nocturia x 4) which has been unresponsive to
maximal medical therapy (an alpha-blocker with 5-alpha reductase inhibitor).
Urodynamics have confirmed bladder outlet obstruction due to an enlarged
prostate. Al of the following are potential surgical therapies for BPH, EXCEPT:
NA (radio wa Open radical p. .M Open adenom
Which of the following pharmacotherapy betters
lfa blockare. ntikolin Fosfodiesteras.
2. Mindre än 4 3. Mindre än 1 4. Omätbart
indre än 10 indre än 4 indre än 1
Your healthy 63-year old patient, Mr. Gore, completes an International Prostate
Symptom Score (IPSS) questionnaire which documents his moderate urinary
symptoms (weak urinary stream, urgency and nocturia x 4). His urinalysis is normal,
his post-void residual is low (15cc), and his prostate is mildly enlarged on
examination. What is the next step in the management of urinary symptoms?
lphablock. . lphareduc. . eferal to uro.eferal to uro.eferal to uro.
A 73-year old male with a history of moderate lower urinary
symptoms (LUTS) is unable to urinate after undergoing a laparoscopic
cholecystectomy (gallbladder excision). All of the following are
potential triggers for his urinary retention, EXCEPT:
3. Diphenhydramin for sleep 4. Rinexin (alpha stimulator)
Prostatitis Ranitidin ravenous o enh
2. Emptying in portions 3. Straining micturition 4. Incomplete emptying
eak stream ptying in po. . Straining m Incomplete emp. . Fr
Dutton and Swindells 'The Stag and Hound' Finding Us Free E-Bulletins Contact Dutton and Swindells 'The Stag and Hound' Pieces of 20 January - 26 March 2011 Pieces of Private view and book launch 15 February, 6-8pm Eight Events Objects, texts, animations and sound works which form Visionaries part of the Institute of Beasts project, that willevolve in the spac
Safety Data Sheet Tetracycline 1. PRODUCT AND COMPANY IDENTIFICATION Product Name: Tetracycline Synonyms/Generic Names: 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12aoctahydro-3,6,10,12,12a- pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide hydrochloride SDS Number: 753.00 Product Use: For Educational Use Only Manufacturer: Columbus Chemical Industries, Inc.